EIGR - Eiger BioPharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts6665
Avg. Estimate-0.75-0.4-2.68-1.89
Low Estimate-0.82-0.87-3.22-3.34
High Estimate-0.71.45-0.650.09
Year Ago EPS-1.2-0.92-3.82-2.68
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4455
Avg. EstimateN/A620k490k30.14M
Low EstimateN/AN/AN/A1.18M
High EstimateN/A2.48M2.48M76.3M
Year Ago SalesN/AN/AN/A490k
Sales Growth (year/est)N/AN/AN/A6,051.00%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.74-0.82-0.95-0.74
EPS Actual-1.2-0.92-0.9-0.75
Difference-0.46-0.10.05-0.01
Surprise %-62.20%-12.20%5.30%-1.40%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.75-0.4-2.68-1.89
7 Days Ago-0.75-0.4-2.68-1.89
30 Days Ago-0.75-0.4-2.68-1.89
60 Days Ago-0.740.04-2.21-2.37
90 Days Ago-0.750.05-2.21-2.29
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEIGRIndustrySectorS&P 500
Current Qtr.37.50%N/AN/A-0.02
Next Qtr.56.50%N/AN/A0.06
Current Year29.80%N/AN/A-0.02
Next Year29.50%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A